JAN 22 AIDAC

The US FDA has scheduled an Anti-Infective Drugs Advisory Committee (AIDAC) Meeting for Thursday, January 22, 2015 to discuss new drug applications (NDAs) 207-500 and 207-501, isavuconazonium sulfate capsules and isavuconazonium sulfate for injection, sponsored by Astellas Pharma Global Development, Inc., respectively for the proposed indications of treatment of invasive aspergillosis and mucormycosis.

See the Announcement